Adocia

Adocia SAS is a biotechnology company. The Company researches and develops protein delivery products for wound healing and tissue regeneration based on growth factors. Adocia is specialized in insulin therapy and the treatment of the diabetic foot ulcer, one of the main complications of diabetes.